SINT Stock Forecast & Price Target

SINTX Technologies is well-positioned to capture a significant portion of the global biomaterials market, which is projected to reach $222.8 billion by 2027. They have a solid financial position with over $17 million in cash as of Q3 2020 and have successfully raised over $46 million in equity funding. With strong leadership and a product that addresses important medical needs, SINTX Technologies is poised for long-term success in the growing healthcare industry.

SINTX Technologies is an OEM ceramics company that has made recent progress with regulatory approvals and the acquisition of SiNAPTIC Surgical, which adds experienced personnel in orthopedic product development and surgeon engagement. However, the company's low revenue and negative EPS pose challenges for successful commercial execution and expansion, especially as it competes with larger, more established orthopedic players. Additionally, the company's heavy reliance on partnerships for platform expansion and the need for significant capital requirements in the future are key risks to consider.